Dr. Vassilis Golfinopoulos joined EORTC Headquarters as Medical Vice Director in September 2012, where he oversees the Medical and Pharmacovigilance, Translational Research, Radiotherapy and Imaging, and Quality of Life Departments. His tasks include development and implementation of the EORTC’s scientific strategy and support of initiatives put forth by the EORTC Board. Vassilis plays an instrumental role in both the organization’s SPECTA (screening patients for efficient clinical trial access) program and Cancer Survivorship initiative. He keeps his feet well-grounded in the EORTC’s daily clinical and translational research efforts through his role as clinical research physician for the EORTC Brain Tumor Group.
Before joining the EORTC, Dr. Golfinopoulos was responsible for the sarcoma, melanoma, germ-cell, and part of the lung cancer inpatient and outpatient clinics at the Bank of Cyprus Oncology Center. Prior to that, he gained clinical experience in the inpatient and outpatient setting with all solid tumor types and research experience in multicenter phase I, II, and III clinical studies at the Ioannina University Hospital.
Vassilis earned his medical degree from the University of Patra Medical School, his Ph.D. from the University of Ioannina, and completed residencies in internal medicine and hematological oncology at the Theagenion Cancer Institute and in medical oncology at the University Hospital of Ioannina. As a research fellow at the Jules-Bordet Institute, he participated in a variety of projects conducted by the Functional Genomics and Translational Research Unit and the Department of Medical Oncology.